TOCILIZUMAB EFFICACY AND SAFETY IN PATIENTS WITH SEVERE SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS

TOCILIZUMAB EFFICACY AND SAFETY IN PATIENTS WITH SEVERE SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS

Show other versions (1)

This article contains results of the research of tocilizumab treatment efficacy and safety in 39 patients with severe systemic juvenile idiopathic arthritis, resistant to standard immunosuppressive treatment. Tocilizumab efficacy analysis has shown 50% of patients with inactive disease after 6 month...

Full description

Bibliographic Details
Main Authors: E.I. Alexeeva, R.V. Denisova, S.I. Valieva, T.M. Bzarova, K.B. Isaeva, E.G. Chistyakova, T.V. Sleptsova, E.V. Mitenko
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2011-05-01
Series:Voprosy Sovremennoj Pediatrii
Online Access:https://vsp.spr-journal.ru/jour/article/view/608

Internet

https://vsp.spr-journal.ru/jour/article/view/608

Similar Items